Choose an Icon to Learn More:
Providing low-income Denver children with the eye care and corrective eyewear they need to be their best in the classroom and in life.
The mission of Von's Vision is to provide low-income Denver children with the eye care and corrective eyewear they need to be their best in the classroom and in life. According to recent data collected by Von’s Vision, 38% of children in the United States need some form of vision correction. Three out of every ten children under six years old have never been seen by an eye doctor for a variety of reasons. Von’s Vision will work to provide solutions to this problem through development of targeted and strategic impact and outreach programs.
Dr. Kirk Matoba offers Medical Eye & Vision Care Services, Low vision evaluation and management for pediatric to geriatric care, and Trial Frame refraction Contrast/tint testing.
Dr. Kirk Matoba is a third generation optometrist with interest in Neuro/head trauma as well as Low Vision and partially sighted. Dr. Emily Matoba has experience in low vision and pediatric exams. She has worked with The William Feinbloom Rehabilitation Center at the Eye Institute as well as perform vision screening for children in The Overbrook School of the Blind. We have been in practice since 1986, and practice solely in Lakewood since 2002. Today we provide comprehensive vision and medical exams. Our Low Vision services include: Trial Frame refraction, contrast/tint testing. Trialing eschenbach low vision devices such as magnifiers, telescopes, maxTv, Max details. We have an OCT and VF for any immediate need. We also have a consult for Orcam to come in and talk about the device with the patient and family.
Providing comprehensive early educational services for infants and children who are blind or visually impaired.
No-cost Eye assessments for infants 6-12 months of age. The American Optometric Association recommends scheduling an infant's first eye exam around six months of age, immediately after the eye undergoes rapid and profound changes and is therefore most vulnerable to interference with healthy development.
Tech for Tykes is a groundbreaking program that is changing the lives of young children with disabilities through the use of assistive technology (AT).
Tech for Tykes is a groundbreaking program that is changing the lives of young children with disabilities through the use of assistive technology (AT). Children with developmental delays or disabilities often have difficulty playing and interacting with the world around them. AT provides them with opportunities to be active participants in life rather than passive bystanders. We hope you will take some time to explore the many valuable tools and resources Tech for Tykes has to offer children, families, caregivers and providers in the early childhood community.
Join us for Foundation Fighting Blindness Virtual VisionWalk and the exclusive premiere of 50 Years of Fighting: Together, We're Winning on Sunday, October 17 at 3:00 p.m. ET featuring highlights of the research and breakthroughs over the last 50 years and special moments from members of our community reflecting on what the Foundation Fighting Blindness has meant to them.
Join us on Sunday, October 17, 2021, at 3 p.m. ET for the exclusive video premiere of ‘50 Years of Fighting: Together, We're Winning.’
To celebrate the Fall Virtual VisionWalk, we’ll be sharing highlights of research breakthroughs over the last 50 years, including special moments from members of our community reflecting on what the Foundation Fighting Blindness has meant to them. You won't want to miss this celebration of the Foundation!
Register yourself and your team for the Virtual VisionWalk at: Give.FightingBlindness.org/VirtualVisionWalk
A virtual program offered to the ocular melanoma (OM) community, as a platform for hope, education, mental wellness, resource sharing, support and camaraderie to allow you to not just survive, but thrive.
Colorado Retina in conjunction with the Melanoma Research Foundation's CURE OM initiative and the University of Denver Center for Oncology Psychology Excellence (C.O.P.E.) recognize that disease treatment extends to the well-being of the whole patient. The Ocular Melanoma Support Alliance (OMSA) is a virtual program offered to the ocular melanoma community, as a platform for hope, education, mental wellness, resource sharing, support and camaraderie to allow you to not just survive, but thrive.
Each month welcome a new guest presenter to speak on differing educational topics within the realm of OM, such as genetic testing, life planning, caregiver and family communication, grief management, clinical research updates, holistic and healthy living, advocacy opportunities, and more to provide you will the resources to continue to live your life on your own terms. We will conclude the meeting each month with an open group discussion moderated by trained mental health professionals who will facilitate a conversation around the emotional, mental, and lifestyle aspects of an OM diagnosis.
Mark your calendar for the remainder of this years’ Ocular Melanoma Support Alliance, support group meetings geared towards those living with ocular melanoma.
UPCOMING DATES: 10/28/21 and 11/18/21
TIME: 6:00-8:00 PM MST
WHERE: Virtual - Zoom
RSVP/LEARN MORE: https://www.eventbrite.com/.../virtual-ocular-melanoma...
Join Zoom Meeting (same login each month): https://us02web.zoom.us/j/8418662811
Thursday, October 28, 2021- Liver Directed Therapyfor OM
Presented by Ryan M. Weight DO, MS
Despite successful treatment of primary uveal melanomas, up to 50% of patients subsequently develop systemic metastasis, with the liver involved in up to 90% of patients. The recognition of the poor prognosis associated with liver metastasis has led to the use of various liver-directed treatment modalities. Dr. Weight will undertake a systematic review of the evidence for management of liver metastases from ocular melanoma. He will provide an in-depth overview of liver directed therapy, systemic treatment options, guidelines on best practice, and what's on the horizon for clinical research for metastatic uveal melanoma.
Thursday, November 18, 2021- Immunotherapy Treatment for OM
Presented by Richard Carvajal, MD
An overview of the treatment of uveal melanoma with immunotherapies and how long-term responses may be achievable by means of new immunological strategies. Dr. Carvajal will speak directly to the encouraging results found for some very recently investigated agents such as the bispecific tebentafusp, for which a remarkably increased one-year overall survival rate, and similarly increased disease control rate, were observed in early phase studies. The drug, tebentafusp used in the clinical trial is the first ever research study to report an improvement in overall survival for patients with metastatic uveal melanoma!
DECEMBER 2021 - NO OMSA meeting in December
Amanda Sisco, MA OSC CME
Supervisor of Oncology at Colorado Retina Associates